Michael Shtutman, associate professor and director of the Functional Genomics Core at the University of South Carolina College of Pharmacy, has received a nearly $4 million R01 grant from the National Institute of Neurological Disorders and Stroke to investigate whether common blood pressure medications could help prevent dementia in people living with HIV.
The five-year grant builds on the college's first interdepartmental R01 grant, a collaboration between researchers in the Department of Drug Discovery and Biomedical Sciences and the Department of Clinical Pharmacy and Outcomes Sciences.
This is an amazing story of collaboration between the two departments.
“This is an amazing story of collaboration between the two departments,” says Michael Wyatt, chair of the Department of Drug Discovery and Biomedical Sciences.
The new grant will allow the team to move from retrospective evidence to direct experimental testing. The multidisciplinary group includes collaborators from pharmacy, psychology, medicine and partner institutions, combining expertise from basic science, clinical research and patient care.
“Our main focus is to change the guideline for prescribing antihypertensive medicine toward drugs that cross the blood-brain barrier,” Shtutman says. “Right now, physicians prescribe more or less at random, so our first goal is to change the recommendation and guide physicians on what to prescribe."
If successful, the findings could extend far beyond people living with HIV. Because blood pressure medications are among the world's most commonly prescribed drugs, identifying therapies that better protect cognitive function could influence treatment decisions for millions of patients concerned about healthy aging.
The project also highlights the promise of drug repurposing, an emerging National Institutes of Health priority, and positions the USC College of Pharmacy at the forefront of discovering new uses for existing medications.
